← Back to Search

Emotional Support Plan - Self Guided (ESP-S) for Autism Spectrum Disorder

N/A
Waitlist Available
Led By Vanessa H Bal, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Previous ASD diagnosis
Has smartphone (to access the ESP app)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 week monitoring period
Awards & highlights

Study Summary

This study is evaluating whether a program that provides emotional support can help autistic students.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism
  • Depression and Anxiety

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 week monitoring period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 week monitoring period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)
Change in distress on Ecological Momentary Assessment (EMA) reports
Change in distress on Patient Health Questionnaire (PHQ-9)
Secondary outcome measures
Change Young Adult Coping Orientation for Problem Experience (YA-COPE)
Change in Adult Behavior Checklist
Change in Adult Self Report
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Emotional Support Plan - Self Guided (ESP-S) + 4x Daily MonitoringExperimental Treatment1 Intervention
Participants in this arm will be prompted on their phones 4x/day, to report on activities, mood, suicidal ideation, distress level and ESP use since the last prompt. They will be asked to complete questionnaires weekly for the first 6 weeks and then biweekly for the remaining 9 weeks of the term.
Group II: Emotional Support Plan - Clinician Guided (ESP-C) + 4x Daily MonitoringExperimental Treatment1 Intervention
Participants in this arm will be prompted on their phones 4x/day, to report on activities, mood, suicidal ideation, distress level and ESP use since the last prompt. They will also participate in brief assessment visits conducted weekly for the first 6 weeks and then biweekly for the remaining 9 weeks of the term.
Group III: Emotional Support Plan - Clinician Guided (ESP-C) + (Bi)Weekly MonitoringExperimental Treatment1 Intervention
This will involve brief assessment visits throughout the fall semester, without prompting to use the ESP-C. Visits will be weekly for the first 6 weeks and then biweekly for the remaining 9 weeks of the term.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Emotional Support Plan - Clinician Guided (ESP-C)
2021
N/A
~20
Emotional Support Plan - Self Guided (ESP-S)
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Organization for Autism ResearchOTHER
6 Previous Clinical Trials
132 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
70 Patients Enrolled for Autism Spectrum Disorder
Rutgers, The State University of New JerseyLead Sponsor
426 Previous Clinical Trials
64,242 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
158 Patients Enrolled for Autism Spectrum Disorder
Vanessa H Bal, PhDPrincipal InvestigatorRutgers University - New Brunswick
1 Previous Clinical Trials
13 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
13 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Mar 2025